Salarius Pharmaceuticals (SLRX) Stock Chart & Stock Price History $0.53 -0.05 (-9.14%) Closing price 04:00 PM EasternExtended Trading$0.52 0.00 (-0.57%) As of 07:47 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Chart Stock AnalysisChartCompetitorsEarningsFDA EventsHeadlinesOwnershipSEC FilingsShort InterestTrendsBuy This Stock Salarius Pharmaceuticals Stock Price Performance The Salarius Pharmaceuticals (SLRX) stock chart highlights key performance trends across multiple timeframes. Over the last 12 months, the stock's price has decreased 71.67%, with a year-to-date return of -71.36%. In the past month, the stock has decreased 40.79%, reflecting recent market activity. As of the latest close, Salarius Pharmaceuticals traded at $0.58 with a market cap of $1.24 million and volume of 1.08 million shares. Five years ago, the stock traded at a split-adjusted price of $238.00, representing a 99.78% decrease over that period. At the time, it had a market cap of $15.97 million and a volume of 42,301 shares. Receive SLRX Stock News and Ratings via EmailSign-up to receive the latest news and ratings for Salarius Pharmaceuticals and its competitors with MarketBeat's FREE daily newsletter. Email Address 5 Day Performance-16.35%1 Month Performance-40.79%3 Month Performance-28.01%Year-To-Date Performance-71.36%1 Year Performance-71.67%5 Year Performance-99.78% SLRX Stock Chart for Wednesday, August, 6, 2025 SLRX Chart by TradingView Salarius Pharmaceuticals Stock Price History Daily Weekly Monthly Yearly Time Frame Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year 3 Year 5 Year Time Frame Start Date End Date Export to Excel DateOpening PriceClosing PriceHighLowVolumeMarket Capitalization08/06/2025$0.58$0.53-9.14%$0.59$0.52731,017 shs$1.12 million08/05/2025$0.61$0.58-4.92%$0.63$0.571.08 million shs$1.24 million08/04/2025$0.63$0.61-3.17%$0.67$0.59594,222 shs$1.30 million08/01/2025$0.60$0.63+5.12%$0.70$0.594.04 million shs$1.34 million07/31/2025$0.78$0.60-23.44%$0.73$0.592.15 million shs$1.28 million07/30/2025$1.00$0.78-21.69%$0.92$0.735.46 million shs$1.67 million07/29/2025$0.74$1.00+34.88%$2.31$0.9798.18 million shs$2.13 million07/28/2025$0.75$0.74-1.19%$0.80$0.72158,164 shs$1.58 million07/25/2025$0.75$0.75-0.17%$0.78$0.71251,676 shs$1.60 million07/24/2025$0.70$0.75+7.33%$0.77$0.68373,154 shs$1.60 million Get the Latest News and Ratings for SLRX and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Salarius Pharmaceuticals and its competitors with MarketBeat's FREE daily newsletter. 07/23/2025$0.71$0.70-1.44%$0.73$0.6897,934 shs$1.49 million07/22/2025$0.73$0.71-2.18%$0.75$0.67133,199 shs$1.51 million07/21/2025$0.61$0.73+18.09%$0.75$0.62267,216 shs$1.55 million07/18/2025$0.61$0.61+0.26%$0.65$0.61120,390 shs$1.31 million07/17/2025$0.63$0.61-2.68%$0.66$0.60242,070 shs$1.31 million07/16/2025$0.68$0.63-7.20%$0.70$0.61318,166 shs$1.34 million07/15/2025$0.68$0.68+0.15%$0.69$0.65172,854 shs$1.45 million07/14/2025$0.75$0.68-9.36%$0.72$0.64457,176 shs$1.44 million07/11/2025$0.78$0.75-3.98%$0.81$0.67187,676 shs$1.59 million07/10/2025$0.76$0.78+3.03%$0.89$0.71147,593 shs$1.66 million07/09/2025$0.79$0.76-4.29%$0.89$0.661.08 million shs$1.61 million07/08/2025$0.83$0.79-4.53%$0.85$0.7890,792 shs$1.68 million07/07/2025$0.89$0.83-7.02%$0.87$0.7591,959 shs$1.76 million Related Companies VIVS Stock Chart ENSC Stock Chart TCRT Stock Chart XBIO Stock Chart MTNB Stock Chart INM Stock Chart INDP Stock Chart DRMA Stock Chart CMND Stock Chart ADIL Stock Chart Receive SLRX Stock News and Ratings via EmailSign-up to receive the latest news and ratings for Salarius Pharmaceuticals and its competitors with MarketBeat's FREE daily newsletter. This page (NASDAQ:SLRX) was last updated on 8/6/2025 by MarketBeat.com Staff From Our PartnersElon’s NEXT Big IPO?Cancel your internet TODAY!? Take your latest internet bill and light it on fire… then count the seconds it...Banyan Hill Publishing | SponsoredGuess Who the Gvt Could Partner With Next?The Government Just Made a $400M Bet. Who's Next? A $100 trillion wealth shift is quietly underway... and t...Stansberry Research | SponsoredGENIUS Act: Cancel Your Money?A new law called the GENIUS Act could quietly trigger the most radical shift in American finance in decades. B...Priority Gold | Sponsored[Warning] Buffett Indicator hits new All-Time-HighWarren Buffett has leaned on one key indicator for decades—and it just hit an all-time high. That’s not bullis...Golden Portfolio | Sponsored[Shocking New Report] U.S. Dollar To Crash?The "Death Spiral" Threatening Your Savings But this time, it's not just Dalio ringing the alarm bells…Goldco Precious Metals | SponsoredAmazon’s big Bitcoin embarrassmentBitcoin just passed Amazon in total market cap — but most investors are missing the bigger opportunity. Whi...Brownstone Research | SponsoredINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredREVEALED FREE: Our top 3 stocks to own in 2025 and beyondEvery time Weiss Ratings flashed green like this, the average gain on each and every stock has been 303% (incl...Weiss Ratings | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Salarius Pharmaceuticals, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Salarius Pharmaceuticals With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
